Hematology

What breakthroughs are redefining multiple myeloma treatment and patient outcomes?

How is the field of hematology evolving? In this episode, Dr. Gupta explores groundbreaking innovations from stem cell donation to the use of artificial intelligence in advancing blood science and patient care.

In this episode, Claudio Cerchione recaps the 2025 International Myeloma Society (IMS) Annual Meeting, highlighting key advances in treatment, the evolving research landscape, and more.

Catherine Glass chats with Rob Pieters, Professor of Pediatric Oncology and co-founder of the Princess Máxima Center, Europe’s largest childhood cancer center.

What are myeloproliferative neoplasms, and what can research reveal about future therapies? Andrew Dunbar explores the biology, resistance, and emerging treatment strategies.

Emanuele Angelucci shares the latest on cellular therapies, gene therapy, and breakthroughs in treating haemoglobinopathies.

Steven Okoli, Honorary Senior Clinical Lecturer at Imperial College London, shares how AI, advocacy, and stem cell trials are driving the next chapter in sickle cell care.

Claudio Cerchione explores advances in multiple myeloma, MRD, and CAR-T therapy, with key insights from EHA and ASCO in this Hema Now episode.